Nominations open for Melvin Yahr Parkinson’s Disease Clinical Research Award

Deadline: 11-Jan-2027

The Melvin Yahr Parkinson’s Disease Clinical Research Award supports early-stage clinician scientists worldwide who are conducting clinical research focused on Parkinson’s disease. The one-year award provides $50,000 for eligible research expenses and particularly encourages applications from investigators in under-represented countries and groups, including researchers in Asia, Africa, and Latin America. Jointly supported by the Parkinson’s Foundation and the International Association of Parkinsonism and Related Disorders (IAPRD), the award aims to strengthen diversity and inclusion in Parkinson’s disease research. Funding can support research-related salary expenses for additional trained personnel, equipment, and consumables specifically required for the proposed research plan. The Melvin Yahr Parkinson’s Disease Clinical Research Award is designed for early-stage clinician scientists seeking to advance clinical research in Parkinson’s disease.

The programme aims to:

The award provides a total of $50,000 for a period of one year. The funding can be used for research expenses that are specifically required for the approved research plan.

Eligible expenses may include:

Indirect costs are not allowed. The award focuses on clinical research related to Parkinson’s disease. Supported research should contribute to the programme’s goal of advancing clinical research and translating scientific discoveries into practical measures that can benefit people living with Parkinson’s disease. The award particularly seeks to encourage innovative research conducted by early-stage clinician scientists. The award is open to early-stage investigators based at eligible research institutions worldwide.

Applicants must generally:

The programme particularly encourages applications from investigators in under-represented countries in: The award places particular emphasis on increasing participation from under-represented investigators. It seeks to support early-stage clinician scientists who may contribute new perspectives and approaches to Parkinson’s disease clinical research. Applications from investigators in under-represented countries and groups are particularly encouraged. Applicants must be based at one of the following types of institutions: The institution should provide an appropriate environment for conducting the proposed clinical research. The award can be used for research expenses specifically needed to carry out the approved research plan.

Examples include:

Applicants should ensure that proposed expenses are directly connected to the research activities. Indirect costs are not allowed under the award. Therefore, the proposed budget should focus on eligible direct research expenses associated with the research plan. Applicants should clearly explain the clinical research question they intend to address and how the proposed work could contribute to Parkinson’s disease research. A strong application should clearly communicate: Applicants should carefully check the eligibility and funding conditions before submitting an application. Early-stage clinician scientists play an important role in developing new approaches to clinical research and translating scientific discoveries into healthcare applications. The Melvin Yahr Parkinson’s Disease Clinical Research Award combines research funding with a specific focus on improving diversity and inclusion within the Parkinson’s disease research community. By encouraging applications from under-represented investigators, the programme aims to broaden participation in clinical research and support new contributions to the field. It is a research award supporting early-stage clinician scientists conducting clinical research related to Parkinson’s disease. The award provides $50,000 for one year. The award is jointly supported by the Parkinson’s Foundation and the International Association of Parkinsonism and Related Disorders (IAPRD). Early-stage clinician scientists based at universities, research hospitals, or non-profit research institutions worldwide may apply if they meet the required degree, specialty, and career-stage conditions. Yes. Applicants must hold an MD degree. Applicants should specialize in neurology, psychiatry, physical medicine and rehabilitation, or related fields. Applicants must either be under 35 years old or be within five years of completing their residency program. Yes. The award is open to eligible early-stage investigators worldwide. Yes. Applications from investigators in under-represented countries in Asia, Africa, and Latin America are particularly encouraged. The funding can support research expenses such as salary support for additional trained personnel, equipment, and consumables specifically needed for the research plan. No. Indirect costs are not allowed. The award aims to advance clinical research in Parkinson’s disease, stimulate innovation, support translation of scientific discoveries into practical health measures, and encourage greater diversity among clinician scientists in the field. The Melvin Yahr Parkinson’s Disease Clinical Research Award provides $50,000 for one year to support early-stage clinician scientists advancing clinical research in Parkinson’s disease. With eligibility for investigators worldwide and particular encouragement for researchers from under-represented countries in Asia, Africa, and Latin America, the award provides an opportunity to develop innovative research while contributing to a more diverse Parkinson’s disease research community. For more information, visit Parkinson’s Foundation.